Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly

Trial Details

NCT ID
NCT06712420
Phase
PHASE3
Sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Status
RECRUITING
Cancer Type
Bladder Cancer
Interventions
  • neoadjuvant chemotherapy
  • curative surgery
Locations (sample)
  • Delhi, National Capital Territory of Delhi, India|28.65195,77.23149
  • Delhi, National Capital Territory of Delhi, India|28.65195,77.23149
  • Delhi, National Capital Territory of Delhi, India|28.65195,77.23149

Key Eligibility Criteria

  • Locally advanced resectable GBC defined as Clinical T3/4 disease or Regional LN involvement on imaging studies.
  • Post cholecystectomy GBC with residual disease on imaging, History of bile spillage during primary surgery , history of piece-meal removal of gall …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Bladder Cancer Trials on Trialify →